Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Cyclic hexadepsipeptide mycotoxin produced by C...
Xanthine derivative; PDE inhibitor.
Akt inhibitor.
Side chain attached to various taxanes.
Dihydropyridine; L-type Ca2+ channel blocker.
Phytoestrogen, isoflavone found in various plan...
NSAID; COX-2 inhibitor.
5-fluorouracil prodrug, pyrimidine analog; thym...
CDK2/4/6 inhibitor
Minor kavalactone originally found in Piper met...
Cathepsin K inhibitor.
FIASMA, L-type Ca2+ channel blocker, D2 antagon...
Alkaloid originally found in species of Aconitu...
Peptide produced in tomato leaves; potential ca...
Synthetic peptide, vasopressin analog; AVPR1 ag...
α2-adrenergic and imidazoline-1 antagonist, AT...
Protein translocation inhibitor.
Fluoroquinolone, optically active isomer of ofl...
VEGFR2, PDGFR, FGFR2 inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...